Seattle institute shares favorable results for malaria vaccine

06/30/2009 | Seattle Times, The

Researchers at Seattle Biomedical Research Institute have successfully engineered the genes of malaria-carrying parasites and used these to create an experimental vaccine that proved 100% effective in tests on rats and mice. The researchers plan to test the vaccine candidate on humans next year.

View Full Article in:

Seattle Times, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI